LivaNova (LIVN) Capital Expenditures Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 22.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.97% |
| Dec 31, 2025 | 52.25% |
| Sep 30, 2025 | 55.88% |
| Jun 30, 2025 | 35.22% |
| Mar 31, 2025 | 27.43% |
| Dec 31, 2024 | 11.12% |
| Sep 30, 2024 | 77.03% |
| Jun 30, 2024 | 23.83% |
| Mar 31, 2024 | -8.01% |
| Dec 31, 2023 | 25.22% |
| Sep 30, 2023 | -5.98% |
| Jun 30, 2023 | -15.44% |
| Mar 31, 2023 | -3.67% |
| Dec 31, 2022 | 5.00% |
| Sep 30, 2022 | 0.20% |
| Jun 30, 2022 | 6.62% |
| Mar 31, 2022 | -3.15% |
| Dec 31, 2021 | -16.16% |
| Sep 30, 2021 | -34.86% |
| Jun 30, 2021 | -1.21% |
| Mar 31, 2021 | 12.03% |
| Dec 31, 2020 | -9.68% |
| Sep 30, 2020 | 4.93% |
| Jun 30, 2020 | 8.35% |
| Mar 31, 2020 | 4.35% |
| Dec 31, 2019 | -5.78% |
| Sep 30, 2019 | -21.20% |
| Mar 31, 2019 | -10.98% |